in vitro antifungal activities of euphorbia macroclada and fluconazole against pathogenic candida species
Authors
abstract
background and purpose: candida species constitute an important group of opportunistic fungi, which cause various clinical diseases. considering the resistance of some candida species to conventional antifungal agents, treatment of such cases may be challenging and complicated. the purpose of this study was to evaluate and compare the antifungal activities of euphorbia macroclada latex and fluconazole against different candida species. materials and methods: a total of 150 candida isolates including c. albicans (n=77), c. glabrata (n=28), c. parapsilosis (n=23), c. tropicalis (n=15), c. krusei (n=4), c. famata (n=1), c. kefyr (n=1) and c. inconspicua (n=1) were included in this study. in vitro antifungal activities of euphorbia macroclada latex and fluconazole against these candida species were evaluated, according to m27-a2 protocol on broth macrodilution method by the clinical and laboratory standards institute (clsi). results: among 150 candida isolates, 98 isolates (65.33%), i.e., c. albicans (n=41), c. glabrata (n=23), c. tropicalis (n=12) and c. parapsilosis (n=22) with minimal inhibitory concentration (mic) ≤ 8 μg/ml were susceptible to fluconazole. resistance to fluconazole was noted in 15 isolates, i.e., c. albicans (n=10), c. glabrata (n=2), c. krusei (n=1), c. kefyr (n=1), and c. inconspicua (n=1), with mics of 64 µg/ml. the remaining isolates (n=37) including c. albicans (n=26), c. glabrata (n=3), c. tropicalis (n=3), c. parapsilosis (n=1), c. krusei (n=3) and c. famata (n=1) with mic= 16-32 µg/ml showed dose-dependent susceptibility. the latex of euphorbia macroclada was able to inhibit the growth of 30 out of 150 tested candida isolates with mic range of 128-512 µg/ml. these isolates were as follows: c. albicans (n=2), c. glabrata (n=4), c. parapsilosis (n=19), c. krusei (n=2) and c. tropicalis (n=3). compared to other isolates, higher mic values were noted for c. albicans and c. glabrata (512 µg/ml), respectively. conclusion: the latex of euphorbia macroclada showed notable antifungal activities against some pathogenic candida species. therefore, it can be potentially used as an alternative antifungal agent in future. however, further research is required to identify its active components.
similar resources
In vitro antifungal activities of Euphorbia macroclada and fluconazole against pathogenic Candida species
Background and Purpose: Candida species constitute an important group of opportunistic fungi, which cause various clinical diseases. Considering the resistance of some Candida species to conventional antifungal agents, treatment of such cases may be challenging and complicated. The purpose of this study was to evaluate and compare the antifungal activities of Euphorbia macroclada latex and fluc...
full textIn vitro antifungal activities of Euphorbia macroclada and fluconazole against pathogenic Candida species
BACKGROUND AND PURPOSE Candida species constitute an important group of opportunistic fungi, which cause various clinical diseases. Considering the resistance of some Candida species to conventional antifungal agents, treatment of such cases may be challenging and complicated. The purpose of this study was to evaluate and compare the antifungal activities of Euphorbia macroclada latex and fluco...
full textIn vitro activities of garlic essential oil against Candida species
Pathogenic Candida species are widely distributed in human and animal hosts. Accordingly, they account for 88% of nosocomial fungal infections and are the fourth cause of hospital-acquired blood infections. Fresh Garlic (Allium sativum) contains a sulfur compound that is composed of an amino acid (cysteine) called Alliin. The compounds in garlic are divided into two groups of sulfur and nonsulf...
full textIn vitro studies of two triazole antifungal agents (voriconazole [UK-109,496] and fluconazole) against Candida species.
A new triazole derivative (voriconazole or UK-109,496) and fluconazole were tested against 249 isolates of Candida spp. representing six species. Voriconazole was 10 to 100 times more potent than fluconazole. Strains with decreased susceptibility to fluconazole were inhibited by relatively low concentrations of voriconazole.
full textIn vitro synergism of simvastatin and fluconazole against Candida species.
Systemic fungal infections are responsible for high mortality rates. Several species of fungi may be involved, but Candida spp. is the most prevalent. Simvastatin is used to lower cholesterol and also exhibits antifungal action. The aim of this study was to evaluate the synergistic action of simvastatin with fluconazole against strains of Candida spp. Susceptibility testing was performed accord...
full textAntifungal Activity of Antidepressant Sertraline against Candida Species In vitro: A Potential Beneficial Association with Fluconazole
Cite this article: Oliveira AS, Martinez-de-Oliveira J, Palmeira-de-Oliveira R, Palmeira-de-Oliveira A, et al. (2017) Antifungal Activity of Antidepressant Sertraline against Candida Species In vitro: A Potential Beneficial Association with Fluconazole. Med J Obstet Gynecol 5(1): 1095. *Corresponding authors Ana Sofia Oliveira, CICS-UBI, Health Sciences Research Center, Faculty of Health Scienc...
full textMy Resources
Save resource for easier access later
Journal title:
current medical mycologyجلد ۱، شماره ۲، صفحات ۷-۱۲
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023